F255-0610 Screening compound: 2-(6-tert-butyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}acetamide

F255-0610 Screening compound: 2-(6-tert-butyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}acetamide
F255-0610 Screening compound: 2-(6-tert-butyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0610
2-(6-tert-butyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0610

Molecular Formula

C30H32N4O3 (C30 H32 N4 O3)

Compound Name

2-(6-tert-butyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}acetamide

IUPAC name

2-(6-tert-butyl-3-oxo-34-dihydro-2H-14-benzoxazin-4-yl)-N-{4-[2-(5-methyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}acetamide

SMILES

CC(C)(C)c(cc1)cc(N2CC(Nc3ccc(CCc4nc(cc(C)cc5)c5[nH]4)cc3)=O)c1OCC2=O

InChI

InChI=1S/C30H32N4O3/c1-19-5-12-23-24(15-19)33-27(32-23)14-8-20-6-10-22(11-7-20)31-28(35)17-34-25-16-21(30(2,3)4)9-13-26(25)37-18-29(34)36/h5-7,9-13,15-16H,8,14,17-18H2,1-4H3,(H,31,35)(H,32,33)

InChI Key

XBGRXQBNCMCCGL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27109755

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.022

Distribution Coefficient, logD

6.007

Water Solubility, LogSw

-5.39

Polar Surface Area

67.228

Acid Dissociation Constant (pKa)

13.72

Base Dissociation Constant (pKb)

5.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

F255-0610 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with F255-0610 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0610?
Check Price and Availability of F255-0610, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0610 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0610
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0610
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0610 available by request